Short Selling
Swing Trader
Concord EFS (CEFT) reported third-quarter earnings that matched expectations as strong transaction growth helped offset the addition of lower-margin revenue and the effects of the overall slowdown in consumer spending. Net income for the quarter ending September was $94.3 million, or 18 cents a share, up from 16 cents a share in the year-earlier period. Excluding the gain resulting from a litigation settlement, earnings were 17 cents a share. Revenue for the period rose 30 percent to $568.3 million. Analysts surveyed by Thomson First Call had been expecting earnings of 17 cents a share and revenue of $556.3 million, on average. Shares of the electronic payments company closed Monday down 83 cents at $15.98.
Cryolife (CRY) reported a third-quarter loss of $19.6 million, or $1.01 per share, compared to a gain of $2.7 million, or 14 cents per share in the year-ago period. Revenue was $16.9 million, down from $22.6 million. Excluding charges of $27.2 million, or 92 cents per share associated with an FDA order, the loss totaled $1.7 million or 9 cents per share. The company said it expects to address the FDA's concerns during the fourth quarter of this year and, if so, generate between $58 and $65 million in revenue in 2003. Shares of the company rose 7 cents to $4.33.
EarthLink (ELNK) reported less-than-expected third quarter losses amid strong broadband subscriber growth and provided a full-year outlook that was in line with Wall Street forecasts. Excluding items, the company lost $645,000, or virtually breakeven on a per-share basis. Revenue for the period rose 6.8 percent to $340.7 million. Analysts surveyed by Thomson First Call had been expecting a loss of 3 cents a share and revenue of $338.6 million, on average. Subscribers to the company's broadband business grew by 77,000, or 68 percent, to 681,000. Looking ahead, the Internet access provider expects to lose 21 to 25 cents a share and record revenue of $1.35 billion to $1.37 billion for the full year, versus analyst expectations of a loss of 24 cents and revenue of $1.37 billion. The stock closed Monday down 2 cents at $5.35.
Exelixis (EXEL) announced a drug-development agreement with GlaxoSmithKline (GSK), which will acquire some $30 million of Exelixis stock for $7 a share -- nearly a 100 percent premium to Monday's closing price of $3.58.
Mylan Laboratories (MYL) reported second-quarter earnings and revenue that rose over year-earlier levels and topped expectations, due primarily by strength in its generic business. The company also reiterated its full fiscal year outlook, but indicated that third quarter earnings my fall a bit short. Net earnings for the quarter ending September were $68.2 million, or 54 cents a share, up from 50 cents in the year-earlier period. Revenue increased 12 percent to $319.5 million. Analysts surveyed by Thomson First Call had been expecting earnings of 50 cents a share and revenue of $286.9 million. The pharmaceutical firm said it anticipates earnings of 48 to 52 cents in the quarter ending December and of $2.05 to $2.09 for the year ending March, versus analyst forecasts of 53 cents and $2.06, respectively. The stock closed Monday up 38 cents at $30.49.
Omnicom (OMC) reported third-quarter earnings that improved over year-earlier levels and matched Wall Street expectations. Net income for the quarter ending September was $126.1 million, or 68 cents a share, up from last year's $114 million, or 61 cents a share. Analysts surveyed by Thomson First Call had been expecting earnings of 68 cents a share, on average. Revenue for the period rose 13 percent to $1.77 billion.
Procter & Gamble (PG) reported first-quarter earnings and revenue that increased over year-earlier levels and topped expectations as growth in volume and market share helped offset continuing economic weakness. Net earnings for the quarter ending September were $1.46 million, or $1.04 a share, up from last year's 79 cents a share. Excluding restructuring charges, core net earnings were $1.12 a share. Net sales rose 11 percent to $10.80 billion. Analysts surveyed by Thomson First Call had been expecting earnings of $1.10 a share and revenue of $10.52 billion, on average. The consumer products giant also reiterated its full fiscal year financial forecasts. The stock, a component of the Dow industrials closed Monday down $2.95 at $85.75.
Qwest Communications International (Q) said late Monday that it will take as much as $40.8 billion in goodwill impairment charges against financial results.
Regis (RGIS) reported first-quarter earnings that topped expectations as strong growth in gross margins offset continued economic weakness and lower-than-expected same-store sales. Net income for the quarter ending September was $19.7 million, or 44 cents a share, up from 36 cents a share in the year-earlier period, and above the average analyst forecast as compiled by Thomson First Call of 43 cents a share. Revenue rose 14 percent to $399 million. Looking ahead, the hair salon operator expects to earn 46 cents in its fiscal second quarter and $1.82 to $1.85 for the full fiscal year, compared with current analyst estimates of 46 cents and $1.82, respectively. The stock closed Monday up 24 cents at $29.60.
Cryolife (CRY) reported a third-quarter loss of $19.6 million, or $1.01 per share, compared to a gain of $2.7 million, or 14 cents per share in the year-ago period. Revenue was $16.9 million, down from $22.6 million. Excluding charges of $27.2 million, or 92 cents per share associated with an FDA order, the loss totaled $1.7 million or 9 cents per share. The company said it expects to address the FDA's concerns during the fourth quarter of this year and, if so, generate between $58 and $65 million in revenue in 2003. Shares of the company rose 7 cents to $4.33.
EarthLink (ELNK) reported less-than-expected third quarter losses amid strong broadband subscriber growth and provided a full-year outlook that was in line with Wall Street forecasts. Excluding items, the company lost $645,000, or virtually breakeven on a per-share basis. Revenue for the period rose 6.8 percent to $340.7 million. Analysts surveyed by Thomson First Call had been expecting a loss of 3 cents a share and revenue of $338.6 million, on average. Subscribers to the company's broadband business grew by 77,000, or 68 percent, to 681,000. Looking ahead, the Internet access provider expects to lose 21 to 25 cents a share and record revenue of $1.35 billion to $1.37 billion for the full year, versus analyst expectations of a loss of 24 cents and revenue of $1.37 billion. The stock closed Monday down 2 cents at $5.35.
Exelixis (EXEL) announced a drug-development agreement with GlaxoSmithKline (GSK), which will acquire some $30 million of Exelixis stock for $7 a share -- nearly a 100 percent premium to Monday's closing price of $3.58.
Mylan Laboratories (MYL) reported second-quarter earnings and revenue that rose over year-earlier levels and topped expectations, due primarily by strength in its generic business. The company also reiterated its full fiscal year outlook, but indicated that third quarter earnings my fall a bit short. Net earnings for the quarter ending September were $68.2 million, or 54 cents a share, up from 50 cents in the year-earlier period. Revenue increased 12 percent to $319.5 million. Analysts surveyed by Thomson First Call had been expecting earnings of 50 cents a share and revenue of $286.9 million. The pharmaceutical firm said it anticipates earnings of 48 to 52 cents in the quarter ending December and of $2.05 to $2.09 for the year ending March, versus analyst forecasts of 53 cents and $2.06, respectively. The stock closed Monday up 38 cents at $30.49.
Omnicom (OMC) reported third-quarter earnings that improved over year-earlier levels and matched Wall Street expectations. Net income for the quarter ending September was $126.1 million, or 68 cents a share, up from last year's $114 million, or 61 cents a share. Analysts surveyed by Thomson First Call had been expecting earnings of 68 cents a share, on average. Revenue for the period rose 13 percent to $1.77 billion.
Procter & Gamble (PG) reported first-quarter earnings and revenue that increased over year-earlier levels and topped expectations as growth in volume and market share helped offset continuing economic weakness. Net earnings for the quarter ending September were $1.46 million, or $1.04 a share, up from last year's 79 cents a share. Excluding restructuring charges, core net earnings were $1.12 a share. Net sales rose 11 percent to $10.80 billion. Analysts surveyed by Thomson First Call had been expecting earnings of $1.10 a share and revenue of $10.52 billion, on average. The consumer products giant also reiterated its full fiscal year financial forecasts. The stock, a component of the Dow industrials closed Monday down $2.95 at $85.75.
Qwest Communications International (Q) said late Monday that it will take as much as $40.8 billion in goodwill impairment charges against financial results.
Regis (RGIS) reported first-quarter earnings that topped expectations as strong growth in gross margins offset continued economic weakness and lower-than-expected same-store sales. Net income for the quarter ending September was $19.7 million, or 44 cents a share, up from 36 cents a share in the year-earlier period, and above the average analyst forecast as compiled by Thomson First Call of 43 cents a share. Revenue rose 14 percent to $399 million. Looking ahead, the hair salon operator expects to earn 46 cents in its fiscal second quarter and $1.82 to $1.85 for the full fiscal year, compared with current analyst estimates of 46 cents and $1.82, respectively. The stock closed Monday up 24 cents at $29.60.